Axeos, the versatile 3D/2D extraoral imaging solution from Dentsply Sirona, recently received the international iF Design Award. The 98-member international jury recognized the device primarily for its form and functionality – in these categories the product achieved the best ratings. Axeos provides general practitioners and specialists with a hybrid system that covers a wide range of dental indications and meets modern imaging requirements: sharp images with the lowest possible dose, various selectable volumes and intuitive operability.
The new extraoral imaging system from Dentsply Sirona, Axeos, has been awarded another prestigious design prize. In 2020, the imaging device received the esteemed Red Dot Award for product design. In 2021, Axeos has received another award by the international iF Design Award. In their evaluation, the 98-member international jury awarded points for the product idea, form, function, distinctiveness and utility. Axeos received superior marks in all areas. The jury members were particularly impressed by its form and functionality, which leads to an increased quality in performance and treatment comfort.
“We are very delighted to receive this award,” said Niels Plate, Group Vice President, Digital Devices & Solutions at Dentsply Sirona. “It confirms our goal of offering our customers solutions that stand for high clinical safety, patient comfort and efficient treatment processes. A successful form and functionality of the device contribute to this.”
Imaging solution for general practitioners and specialists
As a modern imaging solution, Axeos offers excellent image quality in 2D and 3D, flexible volumes, seamless connection to Sidexis 4 software as well as to numerous treatment programs. In addition, several features focus on maximum patient comfort: positioning aids (e.g. unique auto-positioner with patented occlusal bite block, automatic temple width measurement, smart height adjustment) support in rapidly achieving the optimum alignment for the image. Lastly, lighting concepts like ambient light create a more pleasant, calming atmosphere for patients.
With Axeos, both classic standard panoramic exposures – which is especially good for children – and extraoral bite wing exposures can be taken. If desired, Axeos can be equipped with a cephalometric arm (left or right) that can be retrofitted at any time. This versatility also convinces users. Dr. Neal Patel, dentist and owner of the Infinite Smiles clinic in Powell, Ohio, says: “Axeos gives us all the X-ray diagnostic options we need. Both temporomandibular joints can be displayed in one image, we receive information about the airways, and we can take HD images when it comes to special endodontic aspects. The low-dose mode further expands the range of indications.” This makes Axeos an imaging solution particularly beneficial to clinicians in various disciplines.
About the iF Design Award
Every year, the iF Design Award recognizes outstanding design, its relevance to business and everyday life, and distinguishes one of the world’s most important seals of excellence. Awarded in Germany since 1953, the iF label is a reliable sign of good design for both consumers and the design community.
Get more information on Axeos here: www.dentsplysirona.com/axeos
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
